Cargando…

The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use

Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor. In this review we aim to highlight the importance of long non-coding RNAs (lncRNAs) in diagnosis, prognosis and treatment ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Salamini-Montemurri, Martín, Lamas-Maceiras, Mónica, Barreiro-Alonso, Aida, Vizoso-Vázquez, Ángel, Rodríguez-Belmonte, Esther, Quindós-Varela, María, Cerdán, María Esperanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225988/
https://www.ncbi.nlm.nih.gov/pubmed/32326249
http://dx.doi.org/10.3390/cancers12041020
_version_ 1783534181754601472
author Salamini-Montemurri, Martín
Lamas-Maceiras, Mónica
Barreiro-Alonso, Aida
Vizoso-Vázquez, Ángel
Rodríguez-Belmonte, Esther
Quindós-Varela, María
Cerdán, María Esperanza
author_facet Salamini-Montemurri, Martín
Lamas-Maceiras, Mónica
Barreiro-Alonso, Aida
Vizoso-Vázquez, Ángel
Rodríguez-Belmonte, Esther
Quindós-Varela, María
Cerdán, María Esperanza
author_sort Salamini-Montemurri, Martín
collection PubMed
description Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor. In this review we aim to highlight the importance of long non-coding RNAs (lncRNAs) in diagnosis, prognosis and treatment choice, to make progress towards increasingly personalized medicine in this malignancy. We review the effects of lncRNAs associated with ovarian cancer in the context of cancer hallmarks. We also discuss the molecular mechanisms by which lncRNAs become involved in cellular physiology; the onset, development and progression of ovarian cancer; and lncRNAs’ regulatory mechanisms at the transcriptional, post-transcriptional and post-translational stages of gene expression. Finally, we compile a series of online resources useful for the study of lncRNAs, especially in the context of ovarian cancer. Future work required in the field is also discussed along with some concluding remarks.
format Online
Article
Text
id pubmed-7225988
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72259882020-05-18 The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use Salamini-Montemurri, Martín Lamas-Maceiras, Mónica Barreiro-Alonso, Aida Vizoso-Vázquez, Ángel Rodríguez-Belmonte, Esther Quindós-Varela, María Cerdán, María Esperanza Cancers (Basel) Review Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor. In this review we aim to highlight the importance of long non-coding RNAs (lncRNAs) in diagnosis, prognosis and treatment choice, to make progress towards increasingly personalized medicine in this malignancy. We review the effects of lncRNAs associated with ovarian cancer in the context of cancer hallmarks. We also discuss the molecular mechanisms by which lncRNAs become involved in cellular physiology; the onset, development and progression of ovarian cancer; and lncRNAs’ regulatory mechanisms at the transcriptional, post-transcriptional and post-translational stages of gene expression. Finally, we compile a series of online resources useful for the study of lncRNAs, especially in the context of ovarian cancer. Future work required in the field is also discussed along with some concluding remarks. MDPI 2020-04-21 /pmc/articles/PMC7225988/ /pubmed/32326249 http://dx.doi.org/10.3390/cancers12041020 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Salamini-Montemurri, Martín
Lamas-Maceiras, Mónica
Barreiro-Alonso, Aida
Vizoso-Vázquez, Ángel
Rodríguez-Belmonte, Esther
Quindós-Varela, María
Cerdán, María Esperanza
The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
title The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
title_full The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
title_fullStr The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
title_full_unstemmed The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
title_short The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
title_sort challenges and opportunities of lncrnas in ovarian cancer research and clinical use
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225988/
https://www.ncbi.nlm.nih.gov/pubmed/32326249
http://dx.doi.org/10.3390/cancers12041020
work_keys_str_mv AT salaminimontemurrimartin thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT lamasmaceirasmonica thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT barreiroalonsoaida thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT vizosovazquezangel thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT rodriguezbelmonteesther thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT quindosvarelamaria thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT cerdanmariaesperanza thechallengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT salaminimontemurrimartin challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT lamasmaceirasmonica challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT barreiroalonsoaida challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT vizosovazquezangel challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT rodriguezbelmonteesther challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT quindosvarelamaria challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse
AT cerdanmariaesperanza challengesandopportunitiesoflncrnasinovariancancerresearchandclinicaluse